RWD67 Disproportionality Analysis Of Vedolizumab to Identify a Putative Signal Using Real-World Postmarketing Surveillance Data Reported in the FAERS Database
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.2817
https://www.valueinhealthjournal.com/article/S1098-3015(25)05374-4/fulltext
Title :
RWD67 Disproportionality Analysis Of Vedolizumab to Identify a Putative Signal Using Real-World Postmarketing Surveillance Data Reported in the FAERS Database
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)05374-4&doi=10.1016/j.jval.2025.09.2817
First page :
Section Title :
Open access? :
No
Section Order :
12337